Your browser doesn't support javascript.
loading
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety.
Cavanna, Luigi; Proietto, Manuela; Citterio, Chiara; Anselmi, Elisa; Zaffignani, Elena; Stroppa, Elisa Maria; Borsotti, Maria Teresa; Contini, Andrea; Di Girolamo, Gabriella; Quitadamo, Vincenzo Matteo; Bacchetta, Nicoletta; Muroni, Monica; Brescia, Maria Grazia; Delledonne, Marco.
Afiliación
  • Cavanna L; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Proietto M; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Citterio C; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Anselmi E; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Zaffignani E; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Stroppa EM; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Borsotti MT; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Contini A; Nurse Directory Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Di Girolamo G; Nurse Directory Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Quitadamo VM; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Bacchetta N; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Muroni M; Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Brescia MG; Public Health Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Delledonne M; Public Health Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Vaccines (Basel) ; 10(2)2022 Jan 21.
Article en En | MEDLINE | ID: mdl-35214623
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia